Coronavirus Update: FDA Pulls Hydroxychloroquine Emergency Authorization, Germany Acquires Stake In CureVac

Praise And Blame For Actions On Controversial Drug

Plus news on the German government's decision to by a 23% stake in mRNA vaccines company CureVac, and Lilly taking Olumiant into Phase III.  

Shop_Front
London, UK: 'Non-essential' shops across the UK opened their doors again on 15 June after three months of lockdown.

The German government is to take a 23% stake in CureVac AG, which is developing an mRNA-based vaccine against COVID-19.

The federal government insists that the €300m ($338.5m) investment in the company, based in Tübingen in south west Germany, will...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip